细化1型糖尿病1期定义:基于本体论驱动的多胰岛自身免疫异质性分析
15年进展至1型糖尿病的累积发病率从最严格定义的88%(95%CI 85-92%)到最宽松定义的18%(5-40%)不等,说明mIA定义严格程度显著影响风险分层。
要点
- 多胰岛自身抗体阳性儿童15年进展至1型糖尿病的风险随定义严格程度从18%到88%不等。
- 最严格定义(mIA/Persistent/2)进展风险显著高于其他所有组(P<0.0001)。
- 2年短期随访可能有助于对mIA定义较宽松者的风险演变进行分层。
核心结论
- 根据mIA定义的严格程度,15年进展至1型糖尿病的风险从18%到88%显著不同。
- 初始分类可识别最高风险个体,但2年短期随访可能有助于对风险演变进行分层,尤其是对mIA定义较宽松者。
研究设计与样本
- T1DI为芬兰、德国、瑞典和美国遗传风险增高儿童的前瞻性合并数据集。
主要发现
- 865名(5%)儿童为mIA,其中537名(62%)进展至1型糖尿病。
- 15年累积发病率从最严格定义mIA/Persistent/2的88%(95%CI 85-92%)到最宽松定义mIA/Any的18%(5-40%)。
- mIA/Persistent/2进展风险显著高于所有其他组(P<0.0001)。
- 中间严格程度定义显示中间风险,与mIA/Any显著不同(P<0.05);但在未随后达到更高严格程度者中,差异在2年随访内减弱。
- 在具有三种自身抗体的mIA/Persistent/2个体中,2年随访时失去一种自身抗体与进展加速相关。
关键数值与推荐
- mIA/Persistent/2定义:同一访视时两种或以上胰岛自身抗体阳性,且下次访视时两种或以上抗体持续阳性,15年累积发病率88%(95%CI 85-92%)。
- mIA/Any定义:两种胰岛自身抗体阳性,不要求同时阳性或持续阳性,15年累积发病率18%(5-40%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the risk of progression to stage 3 type 1 diabetes based on varying definitions of multiple islet autoantibody positivity (mIA). RESEARCH DESIGN AND METHODS: Type 1 Diabetes Intelligence (T1DI) is a combined prospective data set of children from Finland, Germany, Sweden, and the U.S. who have an increased genetic risk for type 1 diabetes. Analysis included 16,709 infants-toddlers enrolled by age 2.5 years and comparison between groups using Kaplan-Meier survival analysis. RESULTS: Of 865 (5%) children with mIA, 537 (62%) progressed to type 1 diabetes. The 15-year cumulative incidence of diabetes varied from the most stringent definition (mIA/Persistent/2: two or more islet autoantibodies positive at the same visit with two or more antibodies persistent at next visit; 88% [95% CI 85-92%]) to the least stringent (mIA/Any: positivity for two islet autoantibodies without co-occurring positivity or persistence; 18% [5-40%]). Progression in mIA/Persistent/2 was significantly higher than all other groups (P < 0.0001). Intermediate stringency definitions showed intermediate risk and were significantly different than mIA/Any (P < 0.05); however, differences waned over the 2-year follow-up among those who did not subsequently reach higher stringency. Among mIA/Persistent/2 individuals with three autoantibodies, loss of one autoantibody by the 2-year follow-up was associated with accelerated progression. Age was significantly associated with time from seroconversion to mIA/Persistent/2 status and mIA to stage 3 type 1 diabetes. CONCLUSIONS: The 15-year risk of progression to type 1 diabetes risk varies markedly from 18 to 88% based on the stringency of mIA definition. While initial categorization identifies highest-risk individuals, short-term follow-up over 2 years may help stratify evolving risk, especially for those with less stringent definitions of mIA.
引用
- Frohnert BI, Ghalwash M, Li Y, et al. Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity. Diabetes Care. 2023. PMID: 36862942. doi:10.2337/dc22-1960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。